Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was MedOrion founded and what is its primary focus?
- MedOrion was founded in January 2017. It focuses on an AI-based Health Behavior Management Platform that enables health plans and risk-bearing providers to influence their members' health.
- What is MedOrion's total funding to date and its current funding stage?
- MedOrion has raised a total of $8.8 million. Its current funding stage is Series A.
- Which investors participated in MedOrion's Seed rounds?
- Impact First Investments, Naveh Shetrit, TAU Ventures, and iAngels participated in MedOrion's Seed funding rounds in October 2018 and August 2019.
- When did MedOrion raise its first Series A round and who was the lead investor?
- MedOrion raised a $6 million Series A round in July 2021, with 10D as the lead investor.
- What new solution did MedOrion release in November 2024?
- In November 2024, MedOrion released a new CAHPS solution, expanding its behavioral science software offerings.
- When did MedOrion announce its first Health Behavior Management Software for U.S. based health plans?
- MedOrion announced its first Health Behavior Management Software for U.S. based health plans in March 2022.
- What recognition did MedOrion receive in February 2022?
- In February 2022, MedOrion's Health Behavior Software won Pfizer's Vaccines Global Innovation Challenge.
- How many employees does MedOrion currently have?
- MedOrion currently has 42 employees.
- What is the primary use case for MedOrion's HBM platform?
- One primary use case for MedOrion's HBM platform is increasing cancer screening rates, specifically for Colorectal Cancer, among health plan members through AI-driven personalized interventions.